RecruitingNCT06353607
Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.
Sponsor
University Hospital, Basel, Switzerland
Enrollment
730 participants
Start Date
Apr 8, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to explore the genetic information associated with the development of TAA and aAD in individuals without history or syndromic features (Marfan syndrome, Ehlers-Danlos syndrome, Turner syndrome etc.) for aortic disease. For this purpose, whole genome sequencing will be performed in patients with documented aortic aneurysm or/and aortic dissection.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- All adult patients \> 18 years who underwent surgery for aAD or TAA intervention at the University Hospital Basel, starting in 2015.
- All patients who will undergo surgery for aAD or TAA at the University Hospital Basel, beginning in 2024.
Exclusion Criteria2
- Patients will be excluded if they are not able or not willing to provide informed consent.
- Patients with diagnosed heritable vascular disorders, such as Marfan syndrome, Turner Syndrome, Loeyes Dietz and Ehlers-Danlos syndrome.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06353607
Related Trials
Terumo Aortic Global Endovascular Registry
NCT0424646358 locations
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
NCT0708957610 locations
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
NCT063362131 location
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
NCT047476261 location
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
NCT063770331 location